Specifically, the GLP-1 co-secreted cousin PYY(1-36), agonist of the vasoconstrictive Y(1) receptor, is physiologically trimmed by DPP-IV to give rise to the appetite-suppressant, anti-diabetic and blood-brain barrier permeable PYY(3-36) agonist of Y(2) receptor (220)
pancreas, epididymis, seminal vesicles, brain, testis, lungs, large intestine, brown adipose tissue, heart, and muscle
doi: 10.1093/ajcn/44.6.907
Nevertheless, definitive trials to justify LC administration have not been conducted and are increasingly unlikely to be funded
It reduces fat deposits and speeds up metabolism
It activates both GLP-1 and another hormone pathway called GIP, which may enhance the medication impacts